Aviso: para depositar documentos, por favor, inicia sesión e identifícate con tu cuenta de correo institucional de la UCM con el botón MI CUENTA UCM. No emplees la opción AUTENTICACIÓN CON CONTRASEÑA
 

Plazomicin activity against 346 extended-spectrum-beta-lactamase/AmpC producing Escherichia coli urinary isolates in relation to aminoglycoside-modifying enzymes

Thumbnail Image

Download

Plazomicin Activity.pdf (342.98 KB)

Official URL

https://doi.org/10.1128/aac.02454-16

Full text at PDC

Publication date

2016

Authors

Advisors (or tutors)

Editors

Journal Title

Journal ISSN

Volume Title

Publisher

American Society for Microbiology
Citations
Google Scholar
Exportar
DC QDC MarcXML RDF MODS METS ORE-ATOM

URI

https://hdl.handle.net/20.500.14352/112723

Citation

López-Diaz MDC, Culebras E, Rodríguez-Avial I, Rios E, Viñuela-Prieto JM, Picazo JJ, Rodríguez-Avial C. 2017. Plazomicin Activity against 346 Extended-Spectrum-β-Lactamase/AmpC-Producing Escherichia coli Urinary Isolates in Relation to Aminoglycoside-Modifying Enzymes. Antimicrob Agents Chemother 61:10.1128/aac.02454-16. https://doi.org/10.1128/aac.02454-16

Abstract

The activity of plazomicin and clinically relevant aminoglycosides was tested against 346 extended-spectrum-β-lactamase/AmpC-producing Escherichia coli urinary isolates, and the results were correlated with the presence of aminoglycoside-modifying enzymes (AMEs). Data showed that plazomicin was very active against all ESBL/AmpC-producing E. coli urinary isolates. Its activity was not related to the AME genes studied.

Research Projects

Organizational Units

Journal Issue

Description

National R&D Plan, AES 2013

UCM subjects

Ciencias Biomédicas

Unesco subjects

3201.03 Microbiología Clínica

Keywords

Collections

Artículos